Patent directory · USPTO A61K / A61P
Patents matching “Theravance, Inc.”
369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6903070
Glycopeptide carboxy-saccharide derivatives
expired -
US 6897305
Calcium channel drugs and uses
expired -
US 6887866
Short-acting sedative hypnotic agents for anesthesia and sedation
expired -
US 6887976
Glycopeptide phosphonate derivatives
expired -
US 6878686
Cross-linked glycopeptide-cephalosporin antibiotics
expired -
US 6872741
Sodium channel modulators
expired -
US 6872701
Glycopeptide phosphonate derivatives
expired -
US 6872804
Glycopeptide disulfide and thioester derivatives
expired -
US 6858584
Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
expired -
US 6831150
Reductive alkylation process
expired -
US 6828299
Polyhydroxy glycopeptide derivatives
expired -
US 6815555
Substituted phenol compounds useful for anesthesia and sedation
expired -
US 6770621
Polyacid glycopeptide derivatives
expired -
US 6756400
Sodium channel modulators
expired -
US 6750241
Protein kinase inhibitors
expired -
US 6747043
Alkoxy aryl &bgr;2 adrenergic receptor agonists
expired -
US 6693202
Muscarinic receptor antagonists
expired -
US 6686362
Indolinone derivatives
expired -
US 6670376
Aryl aniline &bgr;2 adrenergic receptor agonists
expired -
US 6653323
Aryl aniline &bgr;2 adrenergic receptor agonists
expired -
US 6646012
Sodium channel modulators
expired -
US 6635764
Therapeutic ureas
expired -
US 6635618
Glycopeptide phosphonate derivatives
expired -
US 6620781
Glycopeptide carboxy-saccharide derivatives
expired